ERBB2 and malignant colon neoplasm: Although ITGβ3 has been reported to be necessary for the survival, invasion, and migration of colon cancer cells (10–12), ITGβ3 can also inhibit HER-2 signal transduction and exert a tumor suppressor-like activity in colon cancer cells.